Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seresis for UV-induced skin damage protection
NCT02191813Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2000
- Primary completion
- Jul 2000
01
Overview
A Phase 2 trial of Seresis in photodamage, sponsored by Boehringer Ingelheim. Started Mar 2000; status: completed.
02
Drugs
Seresis
03
Conditions
photodamage
Beyond the preview
Go deeper on NCT02191813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191813.